Screener
Zevra Therapeutics, Inc. ZVRA Gain (loss) on extinguishment of debt
Gain (loss) on extinguishment of debt at other companies
Other financials
Where this comes from
Reported directly by Zevra Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:GainsLossesOnExtinguishmentOfDebt.
The source filing: Zevra Therapeutics, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 5:19 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001434647-26-000068
| Line item | Three months ended June 30, 2026 | Three months ended June 30, 2025 | Six months ended June 30, 2026 | Six months ended June 30, 2025 |
|---|---|---|---|---|
| Income (loss) from operations | 16,777 | (71,039) | 68,923 | (76,401) |
| Other (expense) income: | ||||
| Gain on sale of PRV | — | 148,325 | — | 148,325 |
| Loss on extinguishment of debt | — | — | (2,756) | — |
| Loss on derivative liability | — | — | (7,216) | — |
| Interest expense | — | (2,009) | (1,711) | (3,978) |
| Fair value adjustment related to warrant and CVR liability | (6,408) | (747) | (5,440) | 4,127 |
| Fair value adjustment related to investments | (140) | (2) | (356) | (5) |
ITEM 1.FINANCIAL STATEMENTS
FAQ
- What is Zevra Therapeutics, Inc.'s gain (loss) on extinguishment of debt?
- Zevra Therapeutics, Inc. (ZVRA) reported gain (loss) on extinguishment of debt of $0 in Q2 2026.
- What does gain (loss) on extinguishment of debt mean?
- Gains or losses from retiring debt before maturity — gains when debt is repurchased below par, losses when premiums are paid for early redemption.
Ask your AI about Zevra Therapeutics, Inc.'s gain (loss) on extinguishment of debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude